These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26377117)

  • 1. Corrigendum to 'Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential'[Eur J Heart Fail 2015; 17:764-771].
    Eur J Heart Fail; 2015 Sep; 17(9):985. PubMed ID: 26377117
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to 'A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential' [Eur J Heart Fail 2022;24:466-480].
    Eur J Heart Fail; 2022 Sep; 24(9):1739. PubMed ID: 35606332
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to 'Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart' [Eur J Heart Fail] 2015 August;17(8): 760-763. doi:10.1002/ejhf.315.
    Eur J Heart Fail; 2015 Dec; 17(12):1317. PubMed ID: 26647216
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to 'Clinical picture and risk prediction of short-term mortality in cardiogenic shock' [Eur J Heart Fail] 2015 May;17(5):501-9. doi: 10.1002/ejhf.260.
    Eur J Heart Fail; 2015 Sep; 17(9):984. PubMed ID: 26377116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to 'What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative'[Eur J Heart Fail 2016; 18:66-70].
    Eur J Heart Fail; 2016 Feb; 18(2):217. PubMed ID: 26861040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to 'Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015' [Eur J Heart Fail 2019;21:1329-1337].
    Metra M; Lucioli P
    Eur J Heart Fail; 2020 Apr; 22(4):759. PubMed ID: 32342580
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to 'Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU' [Eur J Heart Fail 2019;21:322-333].
    Eur J Heart Fail; 2020 Jan; 22(1):170. PubMed ID: 32003136
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to 'Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2020;22:181-195].
    Eur J Heart Fail; 2020 Jul; 22(7):1287. PubMed ID: 32945099
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to 'Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry' [Eur J Heart Fail 2020;22:92-102].
    Eur J Heart Fail; 2020 Jul; 22(7):1287. PubMed ID: 32945101
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to 'Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry [Eur J Heart Fail 2021;23:1844-1854].
    Eur J Heart Fail; 2022 Apr; 24(4):732. PubMed ID: 35274422
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to 'Departments involved during the first episode of acute heart failure and analysis of emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort' [Eur J Heart Fail 2019;21:1231-1244].
    Eur J Heart Fail; 2020 Nov; 22(11):2172. PubMed ID: 33459460
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to 'Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy' [Eur J Heart Fail 2021;23:854-871].
    Eur J Heart Fail; 2022 Apr; 24(4):732. PubMed ID: 35301785
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to 'Iron deficiency and risk of early readmission following a hospitalization for acute heart failure' [Eur J Heart Fail 2016;18:880-880].
    Eur J Heart Fail; 2022 Mar; 24(3):591. PubMed ID: 34897918
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to 'High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality' [Eur J Heart Fail 2021;23:919-932].
    Eur J Heart Fail; 2022 Mar; 24(3):591. PubMed ID: 34820986
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to 'Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata' [Eur J Heart Fail 2022;24:1047-1062].
    Eur J Heart Fail; 2022 Oct; 24(10):1995. PubMed ID: 36126686
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to 'Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-b1 pathway' [Eur. J. Med. Chem. 157 (2018) 229-247].
    Li X; Lu C; Liu S; Liu S; Su C; Xiao T; Bi Z; Sheng P; Huang M; Liu X; Wei Y; Zhao L; Miao S; Mao J; Huang K; Gao S; Liu N; Qi M; Liu T; Qin S; Wei L; Sun T; Ning W; Yang G; Zhou H; Yang C
    Eur J Med Chem; 2019 Feb; 163():403. PubMed ID: 30530191
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Assessing the progression of segmental fibrosis in chronic liver disease using extracellular volume fractions" [Eur. J. Radiol. 145 (2021) 110033].
    Ozaki K; Ishida T; Ohtani T; Shimada M; Kimura H; Gabata T
    Eur J Radiol; 2022 Mar; 148():110179. PubMed ID: 35086003
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
    Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
    Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
    Anker SD; Schroeder S; Atar D; Bax JJ; Ceconi C; Cowie MR; Crisp A; Dominjon F; Ford I; Ghofrani HA; Gropper S; Hindricks G; Hlatky MA; Holcomb R; Honarpour N; Jukema JW; Kim AM; Kunz M; Lefkowitz M; Floch CL; Landmesser U; McDonagh TA; McMurray JJ; Merkely B; Packer M; Prasad K; Revkin J; Rosano GM; Somaratne R; Stough WG; Voors AA; Ruschitzka F
    Eur J Heart Fail; 2016 Jun; 18(6):727. PubMed ID: 27324688
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives" [Eur. J. Pharm. Biopharm. 120 (2017) 1-8].
    Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
    Eur J Pharm Biopharm; 2018 Apr; 125():182. PubMed ID: 29428216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.